Adjusted 0 8 0 8 O
gestational 9 20 9 20 B-clinical_variable
age 21 24 21 24 I-clinical_variable
less 25 29 25 29 O
than 30 34 30 34 O
37 35 37 35 37 B-upper_bound
weeks 38 43 38 43 I-upper_bound

Known 0 5 44 49 O
allergy 6 13 50 57 O
to 14 16 58 60 O
cangrelor 17 26 61 70 B-allergy_name
or 27 29 71 73 O
known 30 35 74 79 O
sensitivity 36 47 80 91 O
to 48 50 92 94 O
any 51 54 95 98 O
component 55 64 99 108 O
of 65 67 109 111 O
cangrelor 68 77 112 121 O

Life 0 4 122 126 B-clinical_variable
expectancy 5 15 127 137 I-clinical_variable
of 16 18 138 140 O
at 19 21 141 143 O
least 22 27 144 149 O
15 28 30 150 152 B-lower_bound
days 31 35 153 157 I-lower_bound
at 36 38 158 160 O
study 39 44 161 166 O
entry 45 50 167 172 O

Participants 0 12 173 185 O
who 13 16 186 189 O
have 17 21 190 194 O
been 22 26 195 199 O
receiving 27 36 200 209 O
warfarin 37 45 210 218 B-treatment
( 46 47 219 220 I-treatment
Coumadin 47 55 220 228 I-treatment
® 55 56 228 229 I-treatment
) 56 57 229 230 I-treatment
therapy 58 65 231 238 I-treatment

Participants 0 12 239 251 O
with 13 17 252 256 O
evidence 18 26 257 265 O
of 27 29 266 268 O
severe 30 36 269 275 O
hepatic 37 44 276 283 B-chronic_disease
or 45 47 284 286 I-chronic_disease
renal 48 53 287 292 I-chronic_disease
failure 54 61 293 300 I-chronic_disease
[ 62 63 301 302 O
aspartate 63 72 302 311 B-clinical_variable
aminotransferase 73 89 312 328 I-clinical_variable
( 90 91 329 330 I-clinical_variable
AST 91 94 330 333 I-clinical_variable
) 94 95 333 334 I-clinical_variable
or 96 98 335 337 O
alanine 99 106 338 345 B-clinical_variable
aminotransferase 107 123 346 362 I-clinical_variable
( 124 125 363 364 I-clinical_variable
ALT 125 128 364 367 I-clinical_variable
) 128 129 367 368 I-clinical_variable
greater 130 137 369 376 O
than 138 142 377 381 O
three 143 148 382 387 B-lower_bound
times 149 154 388 393 O
normal 155 161 394 400 O
for 162 165 401 404 O
age 166 169 405 408 B-age
or 170 172 409 411 O
total 173 178 412 417 B-clinical_variable
bilirubin 179 188 418 427 I-clinical_variable
greater 189 196 428 435 I-clinical_variable
than 197 201 436 440 O
20 202 204 441 443 B-lower_bound
milligrams 205 215 444 454 I-lower_bound
( 216 217 455 456 I-lower_bound
mg)/deciliter 217 230 456 469 I-lower_bound
( 231 232 470 471 I-lower_bound
dL 232 234 471 473 I-lower_bound
) 234 235 473 474 I-lower_bound
; 235 236 474 475 O
creatinine 237 247 476 486 B-clinical_variable
greater 248 255 487 494 O
than 256 260 495 499 O
2 261 262 500 501 B-lower_bound
times 263 268 502 507 I-lower_bound
the 269 272 508 511 I-lower_bound
normal 273 279 512 518 I-lower_bound
upper 280 285 519 524 I-lower_bound
limit 286 291 525 530 I-lower_bound
] 291 292 530 531 O

Participation 0 13 532 545 O
in 14 16 546 548 O
another 17 24 549 556 O
investigational 25 40 557 572 B-treatment
therapeutic 41 52 573 584 I-treatment
drug 53 57 585 589 I-treatment
or 58 60 590 592 O
investigational 61 76 593 608 B-clinical_variable
therapeutic 77 88 609 620 I-clinical_variable
device 89 95 621 627 I-clinical_variable
trial 96 101 628 633 I-clinical_variable
within 102 108 634 640 O
30 109 111 641 643 B-upper_bound
days 112 116 644 648 I-upper_bound
of 117 119 649 651 O
starting 120 128 652 660 O
study 129 134 661 666 O

Platelet 0 8 667 675 B-clinical_variable
count 9 14 676 681 I-clinical_variable
less 15 19 682 686 O
than 20 24 687 691 O
100,000 25 32 692 699 B-upper_bound
cells 33 38 700 705 I-upper_bound
/ 38 39 705 706 I-upper_bound
microliter 39 49 706 716 I-upper_bound
( 50 51 717 718 I-upper_bound
µL 51 53 718 720 I-upper_bound
) 53 54 720 721 I-upper_bound

females 0 7 722 729 B-gender

ranging 0 7 730 737 O
in 8 10 738 740 O
age 11 14 741 744 B-age
from 15 19 745 749 O
birth 20 25 750 755 O
through 26 33 756 763 O
28 34 36 764 766 B-upper_bound
days 37 41 767 771 I-upper_bound
of 42 44 772 774 O
life 45 49 775 779 O

